Kathy Nolfo,Concur, Michael Bell,R-Squared & Collene Hoaglin,Trivascular
By law, all pharmaceutical, medical device, biotech and drug wholesale companies, regardless of size, are facing the first annual reporting deadline under the “Open Payments” (aka Sunshine Act) program. With complex Centers for Medicare & Medicaid Services (CMS) reporting requirements, many companies are finding they are challenged by manual reporting and data validation. Finance and Compliance teams have the overwhelming task to compile their data accurately, completely, and timely, or face significant fines or penalties. If your company is confronted with the time consuming task of preparing for the Open Payments reporting, be assured there’s an easier solution to help you gain transparency, streamline reporting, meet the requirements and maintain compliance.
Join Concur, R-Squared, and Trivascular Inc. to learn best practices, tips and solutions to help you process and map your data to meet State, Federal and International disclosure reporting requirements. You will learn about cost-effective solutions designed to validate spend across multiple systems, provide the right level of internal controls, and align with Government report formatting requirements. Hear how Trivascular, an innovative company focused on advancing endovascular aortic repair (EVAR), has streamlined their data capture and integration for Open Payment reporting.